ロード中...
Inflammasomes and pyroptosis as therapeutic targets for COVID-19
The inflammatory response to SARS-CoV-2 infection has a direct impact on the clinical outcomes of COVID-19 patients. Of the many innate immune pathways that are engaged by SARS-CoV-2, we highlight the importance of the inflammasome pathway. We discuss available pharmaceutical agents that target a cr...
保存先:
| 出版年: | J Immunol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7343621/ https://ncbi.nlm.nih.gov/pubmed/32493814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.2000513 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|